Our mission in Lifera is to advance Saudi Arabia’s biopharmaceutical sector and build national health resilience. We were honored to be invited to participate in the “Advanced Therapies Forum” hosted by King Faisal Specialist Hospital and Research Center, which brought together key players both in Saudi Arabia and globally to discuss advancements in cell and gene therapy. This forum provided a unique opportunity to discuss ways to improve patient access, accelerate therapeutic innovation, and elevate Saudi Arabia's role in this fast-growing area of science and medicine. We look forward to the continued momentum and positive impact that will emerge from this event. Congratulations to King Faisal Specialist Hospital and Research Center for being the first institution in the Middle East to deliver commercial CAR-T cell therapies, one of the leading bone-marrow transplant centers globally for Sickle Cell and BMT failure transplants (both inherited and acquired), and a leading institution for allogeneic BMT. Special thanks to Dr. Syed Osman Ahmed for organizing this event and King Faisal Specialist Hospital and Research Center team for collaborating with Lifera. A big thank you to HE Dr.Majid Al Fayyadh, MD, MMM, Dr. Abdulaziz Al Rajhi, MBBS, MBA, FRCPC, and Dr. Hazaa Alzahrani for being open to exploring collaborations with Lifera to expand Cell & Gene Therapy in KSA. Many thanks to our Chairman Dr. Ibrahim Aljuffali for joining the panel with Dr. Adel AlMarshad عادل المرشد, Dr. Ahmed Aljedai, Dr. Hani Choudhry, to discuss the different ways for our Saudi government that can support CGT expansion in the kingdom. Special thanks to Rahul Singhvi, CEO of Resilience for attending and presenting at the event and showcasing how Resilience has developed innovative solutions in CGT. #cell&GeneTherapy #CellAndGeneTherapy مهمتنا في لايفيرا هي تطوير قطاع الأدوية الحيوية في المملكة العربية السعودية وبناء المرونة الصحية الوطنية. وبهذا تشرفت لايفيرا بدعوة مستشفى الملك فيصل التخصصي ومركز الأبحاث للمشاركة في "منتدى العلاجات المتقدمة" والذي جمع أهم الجهات الممثلة على صعيد المملكة و الصعيد العالمي أيضا لمناقشة التطورات في العلاج الخلوي والجيني. وقد أتاح هذا المنتدى فرصة فريدة لمناقشة سبل تحسين وصول العلاج للمرضى، وتسريع الابتكار العلاجي، ورفع دور المملكة في هذا المجال حيث نتطلع إلى الاستمرارية والتأثير الإيجابي الذي سينتج عن هذا الحدث. تهانينا إلى مستشفى الملك فيصل التخصصي ومركز الأبحاث لكونها المؤسسة الأولى في الشرق الأوسط التي تقدم العلاجات الجينية, وواحدة من أهم مراكز زراعة النخاع العظم عالمياً . شكر خاص لجميع من ساهم في انجاح هذا المنتدى الرائع من مختلف الجهات الصحية.
#KFSHRC held the "Advanced Therapies Forum” to bring together the key players aiding the growth of the advanced cell and gene therapy (ACGT) ecosystem locally and globally.
Consultant, Dept of Hematology, Stem Cell Transplant and Cellular Therapy; Director CAR T-Cell Program, Cancer Centre of Excellence
3moThank you to Ibrahim Aljuffali and Jeremy P. for their invaluable contributions and to Lifera . Progress in cell and gene therapy and advanced therapies needs all stakeholders to work in sync to move forward - no one can do this alone ! We Look forward to working with will all parties to offer our patients the best options, the best outcomes and forward the National biotechnology strategy.